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EDITORIAL
Angiotensin II, the AT2 receptor, and
nuclear factor-B activation
Angiotensin (Ang) II induces many proinflammatory inducible transcription factors c-Fos, c-Jun, and Krox.
and growth-inducing effects. The nuclear transcription AT1 signaling activates NF-B by mechanisms imper-
factor-B (NF-B) is important to both. Ang II sig- fectly understood.
nals primarily via two receptors, termed AT1 and AT2.
Most of the Ang II-related actions familiar to us are
AT1 ACTIONSmediated by the AT1 receptor and the intermediate steps
AT1 actions cause vasoconstriction, aldosterone release,have been fairly well explained. Both Ang II receptors
sodium reabsorption, thirst and salt appetite, growth, in-belong to the seven transmembrane-domain receptor
flammation, and innate and acquired immunity.family; but oddly enough, exhibit only 34% homology.
In fact, the AT2 receptor has the same homology to the
somatostatin receptor subtypes as to the AT1 receptor. AT2 SIGNALING
The two Ang II receptors should therefore have substan-
AT2 signaling does not modulate Ca2 or cAMP, nortially different functions.
does it internalize. AT2 signaling activates this proteinAT2 receptor signaling has generated much interest, phosphorylases, PP2A and MAP kinase phosphatase-1but nevertheless remains mysterious [1, 2]. Apparently,
(MKP-1). It produces variable effects on extracellularCa2 and cyclic 3,5 adenosine monophosphate (cAMP)
signal-related protein kinase (ERK)1/2. It may use cera-are not involved and the receptor is not internalized.
mide and arachidonate as second messengers. It alsoThe receptor appears to activate phosphorylases and
activates sodium-bicarbonate symporter and stimulatesattenuates phosphorylation steps important to growth
the production of bradykinin, which, in turn, stimulatessignaling. Mitogen-activated protein (MAP) kinase acti-
the nitric oxide (NO)/cGMP system. Finally, AT2 signal-vation is inhibited presumably by dephosphorylation via
ing activates NF-B by mechanisms that are obscure.the MAP kinase phosphatase, MKP-1 [1]. The activation
or inactivation of extracellular signal-regulated protein
kinase (ERKs) via AT2 is controversial and appears to be AT2 ACTIONS
either condition-, cell-line-, or costimulation-dependent AT2 actions include embryonic growth regulation, in-[1]. Since AT2 receptor expression is most prominent hibition of cell proliferation, neuronal development and
during embryonic development, its role in the adult is cell repair, apoptosis induction, bradykinin, NO, and
even less clear. However, evidence has been submitted in- prostanoid production. It may affect regulated upon acti-
dicating that the AT2 receptor stimulates a vasodilator sig- vation, normal T cell expressed and secreted (RANTES)
naling cascade that includes bradykinin, nitric oxide, and and cyclooxygenase (COX) 2 regulation via NF-B.
cyclic guanosine 3,5 monophosphate (cGMP) in adult In this issue of Kidney International, Wolf et al [3] pre-
animals. These findings suggest that the AT2 receptor may sent evidence that Ang II activates NF-B through both
be relevant to blood pressure regulation. An incomplete AT1 and AT2 receptors in cell culture systems. The AT1comparison between the seven transmembrane-spanning and AT2 receptors were selectively expressed in COS7domains between AT1 and AT2 follows [1, 2]. cells that normally do not express either of these recep-
tors. Rat glomerular endothelial cells expressing both
receptors were also studied. Finally, the investigatorsAT1 SIGNALING
examined PC12 cells that express solely the AT2 recep-AT1 signaling is a G-protein coupled, internalized, phos-
tor. Ang II at 1  107 mol/L induced NF-B DNApholipase C-induced protein kinase C signaling, phospho-
binding in COS7 cells transfected with either receptor,inositol turnover, Ca2 surge. It produces mitogen-acti-
an effect that was blocked by respective AT1 and AT2vated kinases, JAK/Stat pathway, Jun kinase activation,
receptor blockers. The endothelial cells exhibited NF-B
activation through either receptor. The PC12 cells ex-
pressed NF-B when exposed to Ang II, an effect thatKey words: cyclic adenosine monophosphate, extracellular signal-regu-
lated proteins, mitogen-activated proteins, cyclooxygenase, nitric oxide. was inhibited by AT2 receptor blockade. These data are
strong evidence that in the in vitro systems employed, 2002 by the International Society of Nephrology
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Ang II can activate NF-B by either the AT1 or AT2 contribute to the line of investigation explored by Wolf
et al [3, 4] and Ruiz-Ortega et al [5–7]. Such studiesreceptor. The study by Wolf et al provides no direct in
should also address the black box that lies behind thevivo insights but is consistent with earlier findings from
Ang II receptors and NF-B activation. The precisethis group that Ang II leads to release of RANTES, an
chain of events that lies between even AT1 receptorinflammatory chemokine, via the AT2 receptor [4].
stimulation and NF-B activation is imperfectly under-These are not the first data suggesting that Ang II
stood. Ruiz-Ortega’s results and those of others suggestleads to NF-B activation via the AT2 receptor. Ruiz-
that the activation may occur via reactive oxygen speciesOrtega et al [5] studied vascular smooth muscle cells
production. Is nicotinamide adenine dinucleotide phos-(VSMC) and also relied on pharmacologic blockers.
phate in reduced form (NADPH) oxidase or xanthineThey found that NF-B could be activated via the AT2
oxidase activation necessary to this process? What aboutreceptor. Interestingly, antioxidants and ceramide inhib-
the recent observation that the AT2 receptor can binditors blocked NF-B activation via either receptor in
to the AT1 receptor and thereby antagonize the actionstheir studies. A tyrosine kinase inhibitor blocked NF-B
of the AT1 receptor [11]? Many unanswered questionsactivation only via the AT1 receptor. Supportive evi-
remain to be answered. Nevetheless, the necessary toolsdence for the conclusion that the AT2 receptor is relevant
are available.to Ang II-induced NF-B activation also comes from
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they were infused with Ang II. The data support other
findings from this same laboratory derived from chronic REFERENCES
Ang II infusions in rats [7].
1. Stoll M, Unger T: Angiotensin and its AT2 receptor: New insightsThese are interesting investigations that leave many into an old system. Reg Pept 99:175–182, 2001
questions unanswered. More studies must be performed 2. Carey RM, Jin X-H, Siragy HM: Role of the angiotensin AT2
receptor in blood pressure regulation and therapeutic implications.before a diagrammatic schema can be constructed on
Am J Hypertens 14:98S–102S, 2001
these chains of events. Can knockout mice help us fur- 3. Wolf G, Wenzel U, Burns KD, et al: Angiotensin II activates
nuclear transcription factor-B through AT1 and AT2 receptors.ther? Ruiz-Ortega et al performed their studies in AT1A
Kidney Int 61:1986–1995, 2002receptor knockout mice. The AT1B receptor was not dis- 4. Wolf G, Ziyadeh FN, Thaiss F, et al: Angiotensin II stimulates
rupted, although admittedly its expression on VSMC is expression of the chemokine RANTES in rat glomerular endothe-
lial cells. Role of the angiotensin type 2 receptor. J Clin Invest 100:not to be expected. A double-knockout cell line that in-
1047–1058, 1997cludes both AT1A and AT1B receptor might be helpful. 5. Ruiz-Ortega M, Lorenzo O, Ruperez M, et al: Angiotensin II
What about AT2 receptor knockout mice? Two lines of activates nuclear transcription factor B through AT1 and AT2 in
vascular smooth muscle cells: Molecular mechanisms. Circ ResAT2 receptor-disrupted mice have been developed, both 86:1266–1272, 2000
of which live quite well without the AT2 receptor [1, 2]. 6. Ruiz-Ortega M, Lorenzo O, Ruperez M, Suzuki Y, et al: Angio-
tensin II activates nuclear transcription factor-B in aorta of nor-Thus, the AT2 receptor is not crucial to development or
mal rats and in vascular smooth muscle cells of AT1 knockoutsurvival, or, alternatively, other systems compensate for
mice. Nephrol Dial Transplant 16(Suppl 1):27–33, 2001
its absence. AT2 receptor knockout mice have slightly 7. Ruiz-Ortega M, Lorenzo O, Ruperez M, et al: Systemic infusion
of angiotensin II into normal rats activates nuclear factor-kappaincreased blood pressures, slightly increased responses to
B and AP-1 in the kidney: role of AT(1) and AT(2) receptors.agonists, and an increased propensity to left ventricular Am J Pathol 158:1743–1756, 2001
hypertrophy when challenged with Ang II [8]. The latter 8. Senbonmatsu T, Ichihara S, Price E Jr, et al: Evidence for angio-
tensin II type 2 receptor-mediated cardiac myocyte enlargementprocess presumably involves NF-B activation. Their
during in vivo pressure overload. J Clin Invest 106:R25–R29, 2000
cells in culture show slightly increased cell growth re- 9. Siragy HM, Senbonmatsu T, Ichiki T, et al: Increased renal vasodi-
lator prostanoids prevent hypertension in mice lacking the angio-sponses and somewhat reduced apoptosis responses [1].
tensin subtype-2 receptor. J Clin Invest 104:181–188, 1999Vasodilator prostanoid production is increased in AT2 10. Gross V, Schunck WH, Honeck H, et al: Inhibition of pressure
receptor knockout mice, a process that may represent a natriuresis in mice lacking the AT2 receptor. Kidney Int 57:191–202,
2000compensatory response that protects from hypertension
11. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U: Theand facilitates natriuresis [9, 10]. angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol
AT2 receptor knockout mice and their cell lines could Chem 276:39721–39726, 2001
